Skip to content

Fecal microbiota transplantation for Clostridium difficile infection

Fecal microbiota transplantation for Clostridium difficile infection - Fecal microbiota transplantation for Clostridium difficile infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020766
Enrollment
5
Registered
2016-01-27
Start date
2016-01-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Clostridium difficile infection

Interventions

Fecal microbiota transplantation

Sponsors

Shiga University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Refractory CDI (2) Refractory to at least single antibiotic treatment (3) Eligible as a result of screening tests

Exclusion criteria

Exclusion criteria: (1) Unable to find appropriate donor (2) Immunosuppressive state including chemotherapy, HIV infection and prednisolone administration (3) Pregnancy (4) Antibiotic treatment other than refractory Clostridium difficile infection (5) Age under 20 years old (6) Unable to undergo colonoscopy (7) The attending physician determines that the subject is unsuitable for this study

Design outcomes

Primary

MeasureTime frame
Recurrence rate of CDI at 2 months after FMT

Countries

Japan

Contacts

Public ContactShigeki Bamba

Shiga University of Medical Science Division of Gastroenterology

sb@belle.shiga-med.ac.jp077-548-2217

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026